These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26035012)

  • 41. Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019; 17(1):71-75. PubMed ID: 30412417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Research Biobank of the Year Competition of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB): aims and achievements.
    Schröder C; Corfield J; di Donato JH; Meir K; Parodi B; Schmitz AA; Tiran A; Tybring G; Hewitt RE
    Biopreserv Biobank; 2014 Apr; 12(2):154-60. PubMed ID: 24749884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future-proofing biobanks' governance.
    Gille F; Vayena E; Blasimme A
    Eur J Hum Genet; 2020 Aug; 28(8):989-996. PubMed ID: 32424324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of a network-based intra-hospital virtual cancer biobank.
    Zhang L; Wu X; Hu Y; Wang X; He Z; Xie Y; Pan K; Wang N; Dong Z; Zhang L; Ji J
    Biopreserv Biobank; 2015 Feb; 13(1):43-8. PubMed ID: 25686047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
    Boeckhout M; van Dijk J; Legemate DA
    Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biospecimen Complexity-the Next Challenge for Cancer Research Biobanks?
    Watson PH
    Clin Cancer Res; 2017 Feb; 23(4):894-898. PubMed ID: 27551001
    [No Abstract]   [Full Text] [Related]  

  • 47. The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network.
    Quinlan PR; Groves M; Jordan LB; Stobart H; Purdie CA; Thompson AM
    Biopreserv Biobank; 2015 Oct; 13(5):363-70. PubMed ID: 26418270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
    Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
    Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Forward-Thinking" in U.S. Biobanking.
    Cadigan RJ; Edwards TP; Lassiter D; Davis AM; Henderson GE
    Genet Test Mol Biomarkers; 2017 Mar; 21(3):148-154. PubMed ID: 28118036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A practical approach to clinical and research biobanking.
    Yong WH; Dry SM; Shabihkhani M
    Methods Mol Biol; 2014; 1180():137-62. PubMed ID: 25015146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human face of biobank networks for translational research.
    Meir K; Gaffney EF; Simeon-Dubach D; Ravid R; Watson PH; Schacter B; Morente And The Marble Arch International Working Group On Biobanking MM
    Biopreserv Biobank; 2011 Sep; 9(3):279-85. PubMed ID: 24850340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-Quality Biobanks: Pivotal Assets for Reproducibility of OMICS-Data in Biomedical Translational Research.
    Dollé L; Bekaert S
    Proteomics; 2019 Nov; 19(21-22):e1800485. PubMed ID: 31321888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA)].
    Schüttler C; Buschhüter N; Döllinger C; Ebert L; Hummel M; Linde J; Prokosch HU; Proynova R; Lablans M
    Pathologe; 2018 Jul; 39(4):289-296. PubMed ID: 29691676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biobank Quality Management in the BBMRI.be Network.
    Linsen L; T'Joen V; Van Der Straeten C; Van Landuyt K; Marbaix E; Bekaert S; Ectors N
    Front Med (Lausanne); 2019; 6():141. PubMed ID: 31294024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishing and sustaining a biorepository network in Israel: challenges and progress.
    Cohen Y; Almog R; Onn A; Itzhaki-Alfia A; Meir K
    Biopreserv Biobank; 2013 Dec; 11(6):331-8. PubMed ID: 24835362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Stepwise Procedure to Define a Data Collection Framework for a Clinical Biobank.
    Manders P; Peters TMA; Siezen AE; van Rooij IALM; Snijder R; Swinkels DW; Zielhuis GA
    Biopreserv Biobank; 2018 Apr; 16(2):138-147. PubMed ID: 29437488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Versatile, Secure, and Sustainable All-in-One Biobank-Registry Data Solution: The A3BC REDCap Model.
    Willers C; Lynch T; Chand V; Islam M; Lassere M; March L
    Biopreserv Biobank; 2022 Jun; 20(3):244-259. PubMed ID: 34807733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.